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The CBT Debate
For persons with medication-refractory psychotic experiences such as auditory hallucinations, a
psychological therapy referred to as cognitive behavioral therapy for psychosis (CBTp) has emerged
as the standard recommended treatment in clinical practice guidelines (e.g., Kreyenbuhl et al., 2010;
National Institute for Health and Clinical Excellence [NICE], 2014). However, the past few years
have seen impassioned debate regarding the endorsement of CBTp as evidence-based practice, with
some arguing that evidence in its favor has been “oversold” (McKenna and Kingdon, 2014). As a
follow up to their earlier controversial review (Lynch et al., 2010), which claimed no evidence that
CBTp was effective in “well-conducted” trials, a recent meta-analysis by Jauhar et al. (2014) drew
the only slightly less pessimistic conclusion that CBTp’s therapeutic effect was only in the small
range. Coinciding with the continuing recommendation of CBTp for routine provision in the 2014
NICE guidelines, this has led to debates published in several journals, and a flurry of further meta-
analyses analysing different permutations of trial characteristics andmeasures. Thesemeta-analyses
have formed the more optimistic conclusions that CBTp shows good effects for hallucinations (van
der Gaag et al., 2014), for overall psychotic symptoms in people with persisting symptoms (Burns
et al., 2014), and in direct contrasts with other interventions (Turner et al., 2014).
As a battle fought with meta-analysis, debate has focused on which data should be included
in effect size calculations: for example, whether trials with different intervention targets should be
included, conducted during acute psychosis should bemixedwith persisting psychosis, andwhether
both group and one-to-one format intervention should be included (Birchwood et al., 2014; Burns
et al., 2014; Mueser and Glynn, 2014; Peters, 2014). There has also been criticism of an excessive
focus on overall psychotic symptom severity at post-treatment as the primary outcome (e.g., on
measures like the Positive and Negative Symptom Scales, PANSS), when there is stronger evidence
for effects on specific symptom measures (Peters, 2014; van der Gaag et al., 2014), and at follow-up
time points (Peters, 2014), and when, in any case, CBTp primarily targets the emotional impact of
psychotic experiences rather than their presence or frequency (Birchwood et al., 2014).
Beyond the Effect Size Debate
This debate has been valuable in drawing attention to the need for critical thinking in this field.
However, the present paper argues that debate about which data to include in analyses, and how
to interpret them, needs to consider some fundamental limitations of using broad CBTp protocols
as a focus of study, and highlights that this whole debate has overlooked some potentially more
fundamental limitations of what CBTp provides as an intervention for routine practice.
The term “cognitive behavioral therapy for psychosis” emerged in the 1990s within the context of
a number of researchers beginning to study the application of psychological methods to help people
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manage their psychotic symptoms. At this time, this was helpful
in grouping together a number of similar approaches, united by a
pragmatic focus on reducing the impact of symptoms, and use of
methods from a cognitive behavioral tradition, such as training
in different skills in responding to symptoms, and restructur-
ing distress-related appraisals. Hence, the operationalization of
a CBTp served a useful purpose in defining an emerging litera-
ture, in developing therapy manuals for RCTs, and, ultimately,
in providing data for the meta-analyses which have informed
guidelines. However, as the field has progressed, the concept
of CBTp has become less relevant and more limited, both as
an object of scientific enquiry, and as a model of provision in
practice.
Limitations of the CBTp Protocol as an
Object of Scientific Enquiry
One of the key limitations of using CBTp as a trial protocol is
the level of within-trial heterogeneity of therapy delivery. Trials
have usually included persons with some combination of positive
symptoms (hallucinations, delusions, or both), often in combi-
nation with negative symptoms and emotional symptoms, which
means a variety of therapy targets are possible. Intervention pro-
tocols also describe a variety of therapeutic methods (e.g., cop-
ing enhancement, modification of delusions, relapse prevention),
employed on the basis of an individualized case formulation,
which makes it difficult to derive conclusions about the help-
fulness and importance of component methods. In contempo-
rary practice, as further intervention methods are incorporated,
such as the use of mindfulness and imagery, CBTp represents an
increasingly varied smorgasbord of intervention methods used in
various combinations according to the person’s presentation.
One consequence of this within-trial variability is that CBTp
trials have required outcome measures sufficiently broad to cap-
ture the expected (variable) outcome domains. Whilst viable for
broad outcomes such as quality of life and service use, within-
trial variability reduces sensitivity to more direct but individual-
ized outcomes such as hallucination- or delusion-related distress,
compliance with command hallucinations, and interference of
specific symptoms with social functioning. This has resulted in
an overreliance on omnibus psychosis measures like the PANSS,
which are so broad and indirect that they may measure more
things that are not targeted by the intervention than things that
are (Thomas, 2014). Such measures are inevitably going to lack
sensitivity to individual outcomes, and, subsequently, provide tri-
als with little more than a fairly insensitive test of a null hypoth-
esis that CBTp does nothing at all. It would be misleading to
consider the magnitude of effect sizes produced from these data
as especially meaningful.
A second consequence of using an individualized
formulation-based approach is that trials do not reveal which
of the many intervention components that were included in
the intervention contributed to outcome. For example, a recent
review of psychological intervention methods for auditory
hallucinations found that relatively little could be concluded
about the relative usefulness of specific components of CBTp
used with voices, with many assumptions untested, and a need
for much more study at this level (Thomas et al., 2014).
A related, third, limitation regards the amenability of CBTp as
a protocol for RCT designs contrasting with control conditions
that match for therapist time, analogous to the use of placebo
control in drug trials, argued by Lynch et al. to be a feature of
“well-conducted” trials. In principle, this trial design could pro-
vide a strong experimental approach to examining therapeutic
technologies: it would work well if there were a more tightly
operationalised intervention, and more tightly defined outcome
measure, to test whether the specific content of the intervention
contributes over more contextual factors in delivery. However,
this degree of specificity is not provided by the broad CBTp pro-
tocol, where the intervention arm involves a variably utilized
package of intervention methods rather than a specific interven-
tion. This, combined with broad outcome measurement, and the
reality that psychological therapy control conditions have more
active components than placebo/expectancy alone, means that
such designs are likely to be very difficult to power adequately.
Limitations of CBTp as a Model of
Best-Practice Therapy
Meanwhile, the second key issue regards how well the broad
CBTp model, which has been the focus of trials, informs prac-
tice. Ultimately, the purpose of developing any intervention is
to see it delivered. In the 1990s, CBTp was exciting in providing
promise to target symptoms which were being left to pharma-
cotherapy alone. However, whilst clinical practice guidelines have
been encouraging routine provision of CBTp since 2002, there
continues to be discussion of it failing to be delivered (e.g., Farhall
and Thomas, 2013; Nordentoft and Austin, 2014; van der Gaag,
2014). In explaining this, it is often argued that services need
to better prioritize psychological interventions. However, what
does CBTp actually offer? CBTpmainly provides a framework for
adapting existing cognitive and behavioral methods to psychosis,
thereby primarily being suited to delivery by practitioners with
advanced levels of cognitive-behavioral skill, typically clinical
psychologists. Indeed, the competency framework described for
CBTp (Roth and Pilling, 2013) indicates a high and exclusive bar
for delivery. In practice, the CBTp intervention we have validated
as evidence-based practice within RCTs outlines a treatment pro-
tocol requiring such high prerequisite skill that it can only be
used by a small—and expensive—segment of the mental health
workforce.
Furthermore, without understanding which components of
the CBTp black box are useful, this creates a challenge of either
disseminating a simplified version of CBTp to less thoroughly
trained practitioners, or increasing the workforce of skilled ther-
apists. Both have been attempted with less success than would
be hoped. Early initiatives such as THORN in the UK have had
relatively poor success in leading to changes in delivery (Could-
well and Stickley, 2007), and it is notable that the most recent
descriptions of “low intensity” CBT for psychosis have not, in
fact, utilized elements of CBTp, but, rather, behavioral activation
and graded exposure (Waller et al., 2013). Meanwhile, recent UK
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pilots have examined whether it is possible to increase delivery
of CBTp by boosting the workforce of CBT practitioners. Jolley
et al. (2015) recently described the outcomes in a demonstra-
tion site in which a total of 10 additional whole time equivalent
NHS staff focused on delivering CBTp to psychosis services with
approximately 7000 service users. They reported being successful
in leading to a threefold increase in persons delivered CBTp with
evidence for good outcomes and high satisfaction in participants
within a year. However, with delivery reported to increase at a
rate of approximately 20 cases per whole time equivalent thera-
pist per year, the total increase in delivery would have represented
less than 3% of the overall caseload. This suggests that, even with
significant investment and prioritization, only quite low absolute
levels of delivery can be realized, illustrating challenges in meet-
ing consumers’ treatment needs in a widespread way using CBTp
as a model.
What can we Learn from this for the
Ongoing Development of Interventions?
These limitations highlight issues, not of CBTp lacking efficacy,
but of it providing a research focus not particularly revealing
of its component methods or specific effects, and producing an
all-or-nothing therapeutic technology that is not well-suited to
being widely accessed. It is important to recognize when the
CBTp protocol has uses and when it is limited. In research, it
works well as a protocol representing current best-practice expert
psychological therapy, something useful, for example, in con-
trasts with routine care to address cost-effectiveness questions,
or when considering applications in particular contexts, such as
with persons not taking medication (e.g., Morrison et al., 2014).
However, its operationalization is not tight enough to know what
exactly is working. Likewise, in practice, CBTp provides a useful
operationalization of how to work psychologically with psychosis
for persons already fluent in CBT, but is less accessible as an
intervention for practitioners new to CBT to learn.
So what can we learn from this in advancing the field of psy-
chological interventions for psychotic symptoms such as auditory
hallucinations? Being much broader than, for example, cognitive
therapy for depression, CBTp is not well-suited to dismantling
trials. However, there is value in individual examination of more
discrete intervention components, both old and new, that can be
isolated more precisely, which has been showing some success
with delusions (see Freeman, 2011; Thomas et al., 2014). This les-
son is important not just for cognitive behavioral interventions,
but also for the direction of ongoing research into new broad
therapy paradigms being applied to psychotic experiences, such
as acceptance and commitment therapy (e.g., Thomas et al., 2013)
which may run into similar challenges in future.
In doing this, it appears particularly important to be focus-
ing more attention to simple methods amenable to being widely
delivered in practice. In considering the challenges that have
been faced in disseminating CBTp, there is potential value in
questioning the approach of starting with what expert thera-
pists can do, and seeking to disseminate it, and instead starting
with what patients need (e.g., Byrne and Morrison, 2014), and
what mental health practitioners and services can deliver, and
building interventions around this. This might include greater
focus on consumer-defined ideas of personal recovery, and
consumer-identified subjective and functional impacts of psy-
chotic experiences found most problematic; as well as consider-
ing what can be provided by current mental health practitioners,
and new elements such as a growing peer workforce (e.g., Dent-
Pearce et al., 2015) and digital technologies (Alvarez-Jiminez
et al., 2014).
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